london euretina

This meeting has been awarded 20 CME credits

Security Notice

Please note that Kuoni are our only destination management company. Other venders indicating that are operating for the society should be ignored. We never use western union as a payment portal

Posters

Results of intravitreal injections of triamcinolone and ranibizumab in 6 patients with Irvine- Gass syndrome

Poster Details

First Author: C.Efterpi GREECE

Co Author(s):    K. Moschonas   K. Tsakiris               0   0 0   0 0   0 0   0 0

Abstract Details



Purpose:

To display the efficacy of intravitreal injections treatment in 6 patients suffering of Cystoid Macular Edema following cataract operation (Irvine-Gass syndrome).

Setting:

Hellenic Red Cross General Hospital, Ophthalmology Department

Methods:

Six eyes, of six patients that underwent cataract operation with posterior chamber intra-ocular lens implantation, presented with Cystoid Macular Edema. The edema was detected by fundoscopy and by Optical Coherence Tomography. Three of the patients received intravitreal ranibizumab (0.5mg) and three received intravitreal triamcinolone(1cc).

Results:

The patients were evaluated in regular visits, where visual acuity was tested, fundoscopy was performed and OCT examination was done in order to measure retinal thickness and monitor disease progression. In all six patients the visual acuity was improved, and retinal thickness and macular cystoid oedema receded as well.

Conclusions:

Intravitreal therapy with both ranibizumab (0.5mg) and triamcinolone(1cc) was successful in controlling Irvine- Gass syndrome both in terms of BCVA and retinal thickness.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy